GEPHARD/Vivli-Data-Challenge

Genomic–Phenotypic Association for AMR Drug-Target Discovery (GEPHARD): Leverages and links the Vivli AMR Register’s Pfizer-ATLAS surveillance data (African subset) to genomic drivers and provides prioritized targets and compounds to inform stewardship, diagnostics, and early-stage drug discovery Genomic–Phenotypic Association for AMR Drug-Target Discovery (GEPHARD)